Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 8.90
+0.10 (1.14%)
At close: Dec 24, 2025
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €66.97 million as of December 26, 2025. Its market cap has increased by 292.95% in one year.
Market Cap
66.97M
Enterprise Value
65.10M
Revenue
8.09M
Ranking
n/a
PE Ratio
34.30
Stock Price
€8.90
Market Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 66.97M, an increase of 335.73%. That is a compound annual growth rate of 47.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 24, 2025 | 66.97M | 311.14% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.68B |
| Laboratorios Farmaceuticos Rovi | 3.21B |
| Almirall | 2.75B |
| Faes Farma | 1.62B |
| Pharma Mar | 1.32B |
| Clínica Baviera | 763.78M |
| Oryzon Genomics | 250.75M |
| Prim, S.A. | 224.61M |